A Study of Decreased Mental Function Associated With HIV
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare pictures of the brain of HIV-infected people with
memory problems before and after treatment with selegiline. Selegiline is the study drug
received through A5090.
HIV patients generally develop memory problems late in the disease. This will be examined
using noninvasive proton magnetic resonance spectroscopy (1H-MRS). The effect of the drug
selegiline on memory problems also will be examined.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)